Page 30 - bon-dia-aruba-20210128
P. 30

A30     world news
                  Diahuebs 28 Januari 2021

                          Tensions rise as AstraZeneca, EU spar over vaccine delays



                                                                                                                                that  involves  growing  cells,
                                                                                                                                which are injected with a vi-
                                                                                                                                rus, Soriot said. The second
                                                                                                                                involves  turning  this  “drug
                                                                                                                                substance”  into  the  final
                                                                                                                                product, filling vials and test-
                                                                                                                                ing each batch of vaccine.

                                                                                                                                Soriot  said  AstraZeneca  had
                                                                                                                                to reduce deliveries to the EU
                                                                                                                                because plants in Europe had
                                                                                                                                lower  than  expected  yields
                                                                                                                                from  the  biological  process
                                                                                                                                used to produce the vaccine.
                                                                                                                                This  has  also  happened  in
                                                                                                                                other  regions  as  AstraZen-
                                                                                                                                eca sought to rapidly expand
                                                                                                                                production  capacity  to  meet
                                                                                                                                demands from countries bat-
                                                                                                                                tling the pandemic.

                                                                                                                                “We’ve  also  had  teething  is-
                                                                                                                                sues like this in the U.K. sup-
                                                                                                                                ply chain,” Soriot said. “But
                                                                                                                                the U.K. contract was signed
                                                                                                                                three months before the Eu-
                                                                                                                                ropean vaccine deal, so with
                                                                                                                                the  U.K.  we  have  had  an
                                                                                                                                extra three months to fix all
                                                                                                                                the  glitches  we  experienced.
                                                                                                                                As  for  Europe,  we  are  three
                                                                                                                                months  behind  in  fixing
                                                                                                                                those glitches.”
            (AP)  —  The  European  lion  due  to  reduced  yields  The  EU’s  contract  with  As-  well is that Brexit politics is  An  official  from  the  Euro-
            Union  and  drugmaker  from          its   manufacturing  traZeneca is confidential and  playing into this,'' he said.  pean Commission, the EU’s
            AstraZeneca        sparred  plants  in  Europe.  The  EU  can’t be released without the                             executive,  said  the  bloc  has
            Wednesday over a delay in  claimed  Wednesday  that  it  agreement of both sides. The  “This  is  this  is  really,  really  agreed  to  give  336  million
            coronavirus  vaccine  de-    will  receive  even  less  than  EU  has  asked  AstraZeneca  bad  news  —  not  only  bad  euros  ($407  million)  to  As-
            liveries amid a deepening  that  —  just  one  quarter  of  for permission to release the  news for the European coun-  traZeneca to develop its vac-
            dispute  that  raises  con-  the doses that member states  contract, Kyriakides said.  tries  involved,''  he  said.  “I  cine  and  deliver  doses.  The
            cerns  about  international  were supposed to get during                               think  what’s  much  worse  is  official,  who  wasn’t  autho-
            competition  for  limited  January-March 2021.            A third round of talks aimed  that these squabbles between  rized  to  speak  publicly,  said
            supplies of the shots need-                               at  resolving  the  dispute  is  rich  countries  potentially  the  commission  would  be
            ed to end the pandemic.      The  EU  says  it  expects  the  scheduled  for  Wednesday  deny  vaccines  to  people  in  entitled to recover part of the
                                         company  to  deliver  the  full  evening in Brussels.     the rest of the world.”      money  if  the  company  fails
            AstraZeneca  Chief  Execu-   amount  on  time,  and  on                                                             to live up to the terms of this
            tive  Pascal  Soriot  addressed  Monday  threatened  to  put  The  dispute  comes  as  the  AstraZeneca  is  setting  up  advance purchase agreement.
            the dispute for the first time,  export  controls  on  all  vac-  EU,  which  has  450  million  more  than  a  dozen  regional
            rejecting  the  EU’s  assertion  cines made in its territory.  citizens  and  the  economic  supply  chains  worldwide  to  “We  reject  the  logic  of  first
            that the company was failing  Stella Kyriakides, the Europe-  clout  of  the  world’s  biggest  meet  regional  demand  for  come,  first  served,”  Kyria-
            to  honor  its  commitments.  an Commissioner for health  trading  bloc,  lags  far  behind  its  vaccine.  Overall,  Astra-  kides  said.  “That  may  work
            Soriot  said  vaccine  delivery  and food safety, rejected So-  countries like Israel and Brit-  Zeneca plans to deliver up to  at  the  neighborhood  butch-
            figures in AstraZeneca’s con-  riot’s explanation for the de-  ain in delivering coronavirus  3  billion  doses  to  countries  ers, but not in contracts and
            tract with the 27-nation bloc  lays,  saying  that  “not  being  vaccines to its people.  around the world by the end  not in our advance purchase
            were  targets,  not  firm  com-  able to ensure manufacturing                          of 2021.                     agreements.  There’s  no  pri-
            mitments,  and  the  company  capacity  is  against  the  letter  The EU has signed deals for                       ority  clause  in  the  advanced
            was unable to meet them be-  and spirit of our agreement.”  six different vaccines, but so  However,  establishing  each  purchase agreement.”
            cause of problems in rapidly                              far  regulators  have  only  au-  facility is a complicated pro-
            expanding production capac-  Kyriakides  said  AstraZeneca  thorized the use of two, one  cess  that  involves  training  The shortfall in planned de-
            ity.                         should provide vaccines from  made  by  Pfizer  and  another  people  and  ensuring  each  liveries  of  the  AstraZeneca
                                         its UK facilities if it it is un-  by Moderna. The EU’s drug  batch  of  vaccine  is  safe  and  vaccine is coming at the same
            “Our  contract  is  not  a  con-  able  to  meet  commitments  regulator  will  consider  the  effective.  Sometimes  this  time  as  a  slowdown  in  the
            tractual  commitment,  it’s  a  from factories in the EU. The  AstraZeneca  vaccine  on  Fri-  goes  smoothly,  but  in  other  distribution  of  Pfizer-BioN-
            best  effort,’’  Soriot  said  in  comments are certain to cre-  day.                  cases there are problems, So-  Tech shots as Pfizer upgrades
            an interview with the Italian  ate tension in the UK, which                            riot said.                   production facilities at a plant
            newspaper  La  Repubblica.  completed  its  exit  from  the  Robert Yates, director of the                          in Belgium.
            “Basically, we said we’re go-  bloc less than a month ago.  global health program at the  “We  train  them  on  how  to
            ing  to  try  our  best,  but  we                         Chatham  House  think  tank  manufacture,’’  he  said.  “And  “There are a lot of emotions
            can’t  guarantee  we’re  going  “I call on AstraZeneca to en-  in London, said the EU-As-  then,  you  know,  some  peo-  running in this process right
            to  succeed.  In  fact,  getting  gage fully to rebuild trust, to  traZeneca  dispute  highlights  ple  are  new  to  this  process  now, and I can understand it:
            there,  we  are  a  little  bit  de-  provide  complete  informa-  the  danger  of  “vaccine  na-  ...  They  don’t  know  how  to  people want vaccine,” Soriot
            layed.”                      tion and to live up to its con-  tionalism” as countries com-  make the vaccine and they’re  said. “I want the vaccine too,
                                         tractual,  societal  and  moral  pete for limited supplies.  not as efficient as others.″  I want it today. But, at the end
            AstraZeneca  said  last  week  obligations,”  Kyriakides  said                                                      of the day, it’s a complicated
            that  it  planned  to  cut  initial  at  a  media  briefing in  Brus-  “For  politicians,  this  is  red  There are two basic steps in  process.”
            deliveries  in  the  EU  to  31  sels.                    hot.  And,  you  know,  unfor-  producing  the  vaccine.  The
            million  doses  from  80  mil-                            tunately, what we’re seeing as  first  is  a  biological  process
   25   26   27   28   29   30   31   32